Moreover, previous studies have evidenced that both ERK and p38 MAPK positively regulates NF-κB activity in activated HUVECs, and inhibition of these MAPKs decreases NF-κB activation and immune disorders (34, 35). Here, NFKB1 is linked to immune system disorder.